BrainsWay Ltd (nasdaq:BWAY) Share Price

Company Profile

Business description
BrainsWay Ltd is engaged in advanced noninvasive neurostimulation treatments for mental health disorders. The company is advancing neuroscience with its proprietary Deep Transcranial Magnetic Stimulation (Deep TMS) platform technology to improve health and transform lives. Current indications include depressive disorder (including reduction of anxiety symptoms, commonly referred to as anxious depression), obsessive-compulsive disorder, and smoking addiction. Additional clinical trials of Deep TMS in various psychiatric, neurological, and addiction disorders are underway. The company derives revenues from the lease and sale of Deep TMS systems.
Contact
16 Hartum Street
14th Floor, RAD Tower
Har HaHotzvim
Jerusalem9777516
ISR
T: +972 25824030
https://www.brainsway.com
Sector
Healthcare
Stock type
Defensive
Industry
Medical Devices
Fiscal Year End
31 December 2026
Employees
120

Recommended

Headwinds in listed energy stocks likely to have passed

Esther Holloway | 30 March 2026

Potential investors should remember that the company’s controlling shareholder can move markets with a few words.

Franco Granda | 30 March 2026

What we can and can’t learn from the top 20 most shorted ASX shares.

Tyger Fitzpatrick | 30 March 2026

Index	Last price	Change	% Change
All Ordinaries	8,683.90	11.50	0.13%
CAC 40	7,834.88	62.43	0.80%
DAX 40	22,735.61	172.73	0.77%
Dow JONES (US)	45,739.19	523.05	1.16%
FTSE 100	10,203.90	75.94	0.75%
HKSE	24,788.14	37.35	0.15%
NASDAQ	21,177.34	382.70	1.84%
Nikkei 225	51,063.72	822.13	-1.58%
NZX 50 Index	12,912.11	163.19	1.28%
S&P 500	6,433.50	89.78	1.42%
S&P/ASX 200	8,481.80	4.60	0.05%
SSE Composite Index	3,891.86	31.43	-0.80%